Asher J Schranz

1.3k total citations · 1 hit paper
39 papers, 893 citations indexed

About

Asher J Schranz is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Asher J Schranz has authored 39 papers receiving a total of 893 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 24 papers in Infectious Diseases and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Asher J Schranz's work include Infective Endocarditis Diagnosis and Management (18 papers), Antimicrobial Resistance in Staphylococcus (17 papers) and HIV, Drug Use, Sexual Risk (8 papers). Asher J Schranz is often cited by papers focused on Infective Endocarditis Diagnosis and Management (18 papers), Antimicrobial Resistance in Staphylococcus (17 papers) and HIV, Drug Use, Sexual Risk (8 papers). Asher J Schranz collaborates with scholars based in United States. Asher J Schranz's co-authors include Baligh R. Yehia, Craig A. Umscheid, Vincent Lo Re, Aaron T. Fleischauer, David L. Rosen, Vivian H. Chu, Li‐Tzy Wu, William C. Miller, Christopher B. Hurt and Jessica L. Barrett and has published in prestigious journals such as Circulation, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

Asher J Schranz

37 papers receiving 876 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis

2014 340 citations Baligh R. Yehia, Asher J Schranz et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Asher J Schranz United States	12	736	341	322	256	77	39	893
Alice Asher United States	18	1.1k 1.5×	542 1.6×	559 1.7×	480 1.9×	179 2.3×	41	1.5k
Tyler S. Bartholomew United States	17	588 0.8×	100 0.3×	265 0.8×	361 1.4×	135 1.8×	65	764
Rajiv Patel United States	6	855 1.2×	570 1.7×	238 0.7×	340 1.3×	83 1.1×	11	1.0k
Shashi N. Kapadia United States	16	398 0.5×	230 0.7×	152 0.5×	171 0.7×	76 1.0×	59	613
Christine U. Oramasionwu United States	15	295 0.4×	64 0.2×	264 0.8×	121 0.5×	112 1.5×	36	776
Cheryl N. McMahill‐Walraven United States	14	186 0.3×	52 0.2×	252 0.8×	367 1.4×	84 1.1×	40	1.1k
Luigi Cantarutti Italy	15	240 0.3×	91 0.3×	182 0.6×	38 0.1×	85 1.1×	43	751
Katherine Donegan United Kingdom	11	709 1.0×	31 0.1×	152 0.5×	70 0.3×	63 0.8×	20	1.1k
Salvatore Nappa Italy	10	202 0.3×	93 0.3×	428 1.3×	45 0.2×	54 0.7×	22	794
Madhuri Kulkarni India	11	138 0.2×	66 0.2×	299 0.9×	83 0.3×	22 0.3×	30	641

Countries citing papers authored by Asher J Schranz

Since Specialization

Citations

This map shows the geographic impact of Asher J Schranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asher J Schranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asher J Schranz more than expected).

Fields of papers citing papers by Asher J Schranz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asher J Schranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asher J Schranz. The network helps show where Asher J Schranz may publish in the future.

Co-authorship network of co-authors of Asher J Schranz

This figure shows the co-authorship network connecting the top 25 collaborators of Asher J Schranz. A scholar is included among the top collaborators of Asher J Schranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asher J Schranz. Asher J Schranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schranz, Asher J, Mary Figgatt, Vivian H. Chu, Li‐Tzy Wu, & David L. Rosen. (2024). Long-Term Mortality After Drug Use-Associated Endocarditis is High and Differs by Race and Sex: Results of a Statewide Study. Drug and Alcohol Dependence. 260. 110566–110566. 1 indexed citations

Figgatt, Mary, David L. Rosen, Vivian H. Chu, Li‐Tzy Wu, & Asher J Schranz. (2024). Long-term Risk of Serious Infections and Mortality Among Patients Surviving Drug Use–Associated Infective Endocarditis. Clinical Infectious Diseases. 79(1). 56–59. 2 indexed citations

Wurcel, Alysse G., Joji Suzuki, Asher J Schranz, et al.. (2024). Strategies to Improve Patient-Centered Care for Drug Use-Associated Infective Endocarditis. Journal of the American College of Cardiology. 83(14). 1338–1347. 2 indexed citations

Schranz, Asher J, et al.. (2024). Models of Outpatient Parenteral Antimicrobial Therapy Care: One Size May Not Fit All. Clinical Infectious Diseases. 80(4). 930–931.

Figgatt, Mary, Juan M. Hincapie‐Castillo, Asher J Schranz, et al.. (2023). Medications for Opioid Use Disorder and Mortality and Hospitalization Among People With Opioid Use-related Infections. Epidemiology. 35(1). 7–15. 1 indexed citations

Figgatt, Mary, Asher J Schranz, Bradford E. Jackson, et al.. (2023). Mortality associated with bacterial and fungal infections and overdose among people with drug use diagnoses. Annals of Epidemiology. 87. 45–50.e14. 1 indexed citations

Cox, Mary E., et al.. (2023). Endocarditis, drug use and biological sex: A statewide analysis comparing sex differences in drug use-associated infective endocarditis with other drug-related harms. International Journal of Drug Policy. 123. 104280–104280. 3 indexed citations

Figgatt, Mary, Asher J Schranz, Juan M. Hincapie‐Castillo, et al.. (2022). Complications in Using Real-World Data to Study the Health of People Who Use Drugs. Epidemiology. 34(2). 259–264. 2 indexed citations

Wurcel, Alysse G., Jessica Wolpaw Reyes, Keki Balsara, et al.. (2022). Surgeons’ Perspectives on Valve Surgery in People With Drug Use-Associated Infective Endocarditis. The Annals of Thoracic Surgery. 116(3). 492–498. 5 indexed citations

10.

Schranz, Asher J, Paula D. Strassle, Chris B. Agala, et al.. (2021). Pulmonary complications observed in patients with infective endocarditis with and without injection drug use: An analysis of the National Inpatient Sample. PLoS ONE. 16(9). e0256757–e0256757. 9 indexed citations

11.

Figgatt, Mary, et al.. (2021). Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina. Harm Reduction Journal. 18(1). 80–80. 13 indexed citations

12.

Schranz, Asher J & Joshua A. Barocas. (2020). Infective Endocarditis in Persons Who Use Drugs. Infectious Disease Clinics of North America. 34(3). 479–493. 31 indexed citations

13.

Geirsson, Arnar, Asher J Schranz, Oliver K. Jawitz, et al.. (2020). The Evolving Burden of Drug Use Associated Infective Endocarditis in the United States. The Annals of Thoracic Surgery. 110(4). 1185–1192. 33 indexed citations

14.

Tompkins, Kathleen, et al.. (2020). Pneumocystis and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection: A Case Report and Review of an Emerging Diagnostic Dilemma. Open Forum Infectious Diseases. 8(1). ofaa633–ofaa633. 20 indexed citations

15.

Schranz, Asher J, Li‐Tzy Wu, David A. Wohl, & David L. Rosen. (2019). Abstract 11954: Readmission After Discharge Against Medical Advice for Persons With Opioid-Associated Infective Endocarditis. Circulation. 1 indexed citations

16.

Mori, Makoto, Syed Usman Bin Mahmood, Asher J Schranz, et al.. (2019). Risk of reoperative valve surgery for endocarditis associated with drug use. Journal of Thoracic and Cardiovascular Surgery. 159(4). 1262–1268.e2. 23 indexed citations

17.

Schranz, Asher J, Aaron T. Fleischauer, Vivian H. Chu, Li‐Tzy Wu, & David L. Rosen. (2018). Trends in Drug Use–Associated Infective Endocarditis and Heart Valve Surgery, 2007 to 2017. Annals of Internal Medicine. 8 indexed citations

18.

Schranz, Asher J, et al.. (2015). Comparison of HIV Outcomes for Patients Linked at Hospital Versus Community-Based Clinics. AIDS Patient Care and STDs. 29(3). 117–125. 9 indexed citations

19.

Yehia, Baligh R., Asher J Schranz, Craig A. Umscheid, & Vincent Lo Re. (2014). The Treatment Cascade for Chronic Hepatitis C Virus Infection in the United States: A Systematic Review and Meta-Analysis. PLoS ONE. 9(7). e101554–e101554. 340 indexed citations breakdown →

20.

Yehia, Baligh R., Allison L. Agwu, Asher J Schranz, et al.. (2013). Conformity of Pediatric/Adolescent HIV Clinics to the Patient-Centered Medical Home Care Model. AIDS Patient Care and STDs. 27(5). 272–279. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact